Ignite Creation Date:
2024-05-05 @ 5:13 PM
Last Modification Date:
2024-10-26 @ 9:29 AM
Study NCT ID:
NCT00413777
Status:
COMPLETED
Last Update Posted:
2017-07-02
First Post:
2006-12-18
Brief Title:
Tolvaptan Open-label Pilot Efficacy Tolerability and Safety Study in Autosomal Dominant Polycystic Kidney Disease ADPKD
Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Organization Data
Organization:
Otsuka Pharmaceutical Development Commercialization Inc
Class:
INDUSTRY
Study ID:
156-04-250
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Otsuka Pharmaceutical Development Commercialization Inc
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Otsuka Pharmaceutical Co Ltd | INDUSTRY |